Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Expert Review of Medical Devices
|
March 25, 2021
Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders
Joohi Jimenez-Shahed
Neuropsychiatric Disease and Treatment
|
January 26, 2012
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Joohi Jimenez-Shahed
Neurologic Clinics
|
April 14, 2020
Medical and Surgical Treatments of Tourette Syndrome
Joohi Jimenez-Shahed
The Lancet. Neurology
|
April 18, 2015
Design challenges for stimulation trials of Tourette's syndrome
Joohi Jimenez-Shahed
Neurologic Clinics
|
June 27, 2009
Tourette syndrome
Joohi Jimenez-Shahed
Movement Disorders Clinical Practice
|
April 17, 2026
The Dilemma of Longitudinal Follow-Up in MRgFUS
Joohi Jimenez-Shahed
Therapeutic Delivery
|
February 20, 2016
A review of current and novel levodopa formulations for the treatment of Parkinson's disease
Joohi Jimenez-Shahed
International Review of Neurobiology
|
June 24, 2022
Is essential tremor a disorder of GABA dysfunction? No
Steven Bellows, Joohi Jimenez-Shahed
Clinics in Liver Disease
|
November 21, 2018
Chronic Neurologic Effects of Alcohol
Nadia Hammoud, Joohi Jimenez-Shahed
Parkinsonism & Related Disorders
|
July 2, 2014
Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle
Subhashie Wijemanne, Joohi Jimenez-Shahed
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Expert Review of Medical Devices
|
March 25, 2021
Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders
Joohi Jimenez-Shahed
Neuropsychiatric Disease and Treatment
|
January 26, 2012
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Joohi Jimenez-Shahed
Neurologic Clinics
|
April 14, 2020
Medical and Surgical Treatments of Tourette Syndrome
Joohi Jimenez-Shahed
The Lancet. Neurology
|
April 18, 2015
Design challenges for stimulation trials of Tourette's syndrome
Joohi Jimenez-Shahed
Neurologic Clinics
|
June 27, 2009
Tourette syndrome
Joohi Jimenez-Shahed
Movement Disorders Clinical Practice
|
April 17, 2026
The Dilemma of Longitudinal Follow-Up in MRgFUS
Joohi Jimenez-Shahed
Therapeutic Delivery
|
February 20, 2016
A review of current and novel levodopa formulations for the treatment of Parkinson's disease
Joohi Jimenez-Shahed
International Review of Neurobiology
|
June 24, 2022
Is essential tremor a disorder of GABA dysfunction? No
Steven Bellows, Joohi Jimenez-Shahed
Clinics in Liver Disease
|
November 21, 2018
Chronic Neurologic Effects of Alcohol
Nadia Hammoud, Joohi Jimenez-Shahed
Parkinsonism & Related Disorders
|
July 2, 2014
Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle
Subhashie Wijemanne, Joohi Jimenez-Shahed
Page
of 12